BECTON DICKINSON AND CO (BDX)

US0758871091 - Common Stock

239.84  -0.68 (-0.28%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

BECTON DICKINSON AND CO

NYSE:BDX (10/22/2024, 1:28:01 PM)

239.84

-0.68 (-0.28%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month3.87%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap69.32B
Shares
PE18.78
Fwd PE16.65
Dividend Yield1.58%
Analysts
IPO
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

BDX Daily chart

Company Profile

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 73,000 full-time employees. The firm is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. The firm's BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, and pharmaceutical systems. The firm's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The firm's BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Company Info

BECTON DICKINSON AND CO

One Becton Drive

Franklin Lakes NEW JERSEY 07417

P: 12018476800

CEO: Thomas E. Polen

Employees: 73000

Website: https://www.bd.com/

BDX News

News Image8 days ago - Market News VideoO'Reilly Automotive Moves Up In Market Cap Rank, Passing Becton, Dickinson
News Image8 days ago - BD (Becton, Dickinson and Company)BD Announces New Robotics Solution to Automate, Standardize Single-Cell Research

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial launch of the first...

News Image12 days ago - BD (Becton, Dickinson and Company)BD to Announce its Fiscal 2024 Fourth Quarter and Full Year Financial Results

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial...

News Image19 days ago - BloombergBecton Dickinson Hernia-Mesh Settlements Will Exceed $1 Billion

Becton Dickinson & Co. will pay more than $1 billion to resolve more than 38,000 lawsuits alleging medical patients suffered damaged organs from surgical mesh improperly used to treat hernias, according to people familiar with the deal who weren’t authorized to speak publicly.

News Image20 days ago - BloombergBecton Dickinson Settles Vast Majority of Hernia-Mesh Lawsuits

Becton Dickinson & Co. has agreed to settle the vast majority of the thousands of lawsuits claiming hernia patients were harmed by improper surgical mesh made by units of the medical technology giant, ending one of the largest current mass-tort litigations in the US.

News Image20 days ago - BD (Becton, Dickinson and Company)BD Reaches Agreement to Resolve Vast Majority of Hernia Litigation

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has reached an agreement to...

BDX Twits

Here you can normally see the latest stock twits on BDX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example